ICUI
ICU Medical, Inc.
NasdaqGSUSDEQUITY
Healthcare
DELAYED
Buy
+27/100
Last price
159.73
▼ 1.67 (1.03%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
162.55
Prev close
161.40
Day high
162.55
Day low
157.65
Volume
238.61K
Market cap
$3.99B
P/E (TTM)
135.36
52W range
112.50 – 192.85
Day trading desk
Gap from prior close
+0.71%
Prior close 161.40
VWAP
158.90
+0.52% from price
Relative volume
0.67×
Normal
Session range
3.11%
157.65 – 162.55
Position in range
42%
Mid range
ATR (14D)
4.58
2.87% of price
Prior day high
162.81
PDH
Prior day low
157.80
PDL
Bid / ask spread
—
Quote not published
Session volume
184.86K
Avg 277.52K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-2.27%
-4.2%
1M
-4.68%
-5.8%
3M
+5.16%
+0.6%
6M
+33.30%
+15.1%
YTD
+11.96%
-2.3%
1Y
+30.85%
+14.4%
3Y
+34.22%
-48.0%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on ICUI open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
-34.56K
Net selling
Buy transactions
6
9.95K shares
Sell transactions
10
44.51K shares
Net transactions
+16
Buys less sells
Sell : buy shares
4.5 : 1
Mixed
Insider-held shares
438.87K
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Sep 3, 26 | SANZONE VIRGINIA RUTH General Counsel |
SELL | 4.86K | $819.15K | Direct |
| Sep 1, 26 | BONNELL BRIAN MICHAEL Chief Financial Officer |
SELL | 6.38K | $1.12M | Direct |
| Aug 31, 26 | BONNELL BRIAN MICHAEL Chief Financial Officer |
SELL | 9.31K | $1.61M | Direct |
| Aug 13, 26 | WOOLSON DANIEL Officer |
SELL | 5.42K | $982.26K | Direct |
| Aug 12, 26 | SOUSA BEN Chief Technology Officer |
SELL | 2.25K | $401.21K | Direct |
| Aug 11, 26 | FINNEY ELISHA W Director |
SELL | 378 | $68.98K | Direct |
| Aug 11, 26 | VOIGTLANDER CHRISTIAN B Chief Operating Officer |
SELL | 8.93K | $1.63M | Direct |
| May 22, 26 | WOOLSON DANIEL President |
SELL | 2.12K | $280.69K | Direct |
| May 14, 26 | SANZONE VIRGINIA RUTH General Counsel |
SELL | 2.45K | $303.62K | Direct |
| May 13, 26 | HOFFMEISTER DAVID F Director |
— | 1.25K | — | Direct |
| May 13, 26 | KENNEDY KOLLEEN T Director |
— | 1.25K | — | Direct |
| May 13, 26 | GREENBERG DAVID C Director |
CONVERSION | 3.68K | $244.97K | Direct |
| May 13, 26 | FINNEY ELISHA W Director |
— | 1.25K | — | Direct |
| May 13, 26 | ABBEY DONALD M Director |
— | 1.25K | — | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
ABBEY DONALD M |
Director | 6.00K | Conversion of Exercise of derivative security |
BONNELL BRIAN MICHAEL |
Chief Financial Officer | 56.06K | Sale |
FINNEY ELISHA W |
Director | 4.87K | Sale |
GREENBERG DAVID C |
Director | 9.21K | Conversion of Exercise of derivative security |
HERNANDEZ LAURIE |
Director | 4.86K | Conversion of Exercise of derivative security |
HOFFMEISTER DAVID F |
Director | 6.00K | Conversion of Exercise of derivative security |
JAIN VIVEK |
Chief Executive Officer | 279.17K | Conversion of Exercise of derivative security |
SANZONE VIRGINIA RUTH |
General Counsel | 14.60K | Sale |
VOIGTLANDER CHRISTIAN B |
Chief Operating Officer | 37.38K | Sale |
WOOLSON DANIEL |
Officer | 17.06K | Sale |
Fundamentals
Market cap$3.99B
Enterprise value$4.98B
Revenue (TTM)$2.16B
Gross profit$826.24M
EBITDA$326.12M
Net income$30.09M
EPS (TTM)$1.18
Free cash flow$163.56M
Total cash$302.64M
Total debt$1.29B
Book value / share$86.05
Shares outstanding25.01M
Float24.56M
Short % of float7.26%
Dividend yield0.00%
Beta (5Y)0.87
Valuation & profitability ratios
Trailing P/E135.36
Forward P/E16.56
PEG ratio0.08
Price / sales—
Price / book1.86
EV / revenue2.31
EV / EBITDA15.27
Gross margin38.26%
Operating margin7.53%
Profit margin1.39%
Return on equity1.41%
Return on assets1.93%
Debt / equity59.82
Current ratio2.43
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $2.23B | $2.38B | $2.26B | $2.28B | -6.3% |
| Operating revenue | $2.23B | $2.38B | $2.26B | $2.28B | -6.3% |
| Cost of revenue | $1.41B | $1.56B | $1.52B | $1.58B | -9.5% |
| Gross profit | $822.04M | $824.78M | $739.87M | $697.76M | -0.3% |
| Research & development | $87.50M | $88.61M | $85.34M | $92.98M | -1.3% |
| Selling, general & admin | $625.21M | $638.76M | $606.69M | $608.35M | -2.1% |
| Total operating expense | $712.71M | $727.38M | $692.04M | $701.33M | -2.0% |
| Operating income | $109.33M | $97.41M | $47.84M | -$3.57M | +12.2% |
| Net interest income | -$83.03M | -$95.75M | -$95.22M | -$66.38M | +13.3% |
| Pre-tax income | $4.36M | -$66.01M | -$78.30M | -$114.41M | +106.6% |
| Tax provision | $2.44M | $51.68M | -$48.64M | -$40.12M | -95.3% |
| Net income | $732.00K | -$117.69M | -$29.66M | -$74.29M | +100.6% |
| Net income to common | $732.00K | -$117.69M | -$29.66M | -$74.29M | +100.6% |
| Basic EPS | 0.03 | -4.83 | -1.23 | -3.11 | +100.6% |
| Diluted EPS | 0.03 | -4.83 | -1.23 | -3.11 | +100.6% |
| EBIT | $97.70M | $40.53M | $24.43M | -$43.60M | +141.1% |
| EBITDA | $298.44M | $260.04M | $253.20M | $191.55M | +14.8% |
| Basic shares | 24.64M | 24.39M | 24.09M | 23.87M | +1.0% |
| Diluted shares | 24.90M | 24.39M | 24.09M | 23.87M | +2.1% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $307.96M | $308.57M | $254.22M | $208.78M | -0.2% |
| Cash & short-term investments | $307.96M | $308.57M | $254.72M | $213.01M | -0.2% |
| Accounts receivable | $180.51M | $182.83M | $161.57M | $221.72M | -1.3% |
| Inventory | $615.86M | $584.68M | $709.36M | $696.01M | +5.3% |
| Total current assets | $1.19B | $1.44B | $1.22B | $1.24B | -17.4% |
| Property, plant & equipment | $511.89M | $499.30M | $685.52M | $713.58M | +2.5% |
| Goodwill & intangibles | $2.13B | $2.17B | $2.34B | $2.43B | -1.9% |
| Total assets | $4.05B | $4.20B | $4.38B | $4.52B | -3.6% |
| Total current liabilities | $498.86M | $556.18M | $481.84M | $494.56M | -10.3% |
| Current debt | $18.75M | $51.00M | $51.00M | $29.69M | -63.2% |
| Long-term debt | $1.27B | $1.53B | $1.58B | $1.62B | -17.4% |
| Total debt | $1.33B | $1.63B | $1.70B | $1.73B | -18.1% |
| Total liabilities | $1.93B | $2.24B | $2.26B | $2.43B | -13.9% |
| Retained earnings | $690.89M | $690.16M | $807.85M | $837.50M | +0.1% |
| Shareholder equity | $2.12B | $1.97B | $2.12B | $2.09B | +8.1% |
| Working capital | $691.69M | $885.80M | $739.43M | $740.64M | -21.9% |
| Net tangible assets | -$9.49M | -$208.33M | -$219.62M | -$342.10M | +95.4% |
| Shares issued | 24.69M | 24.52M | 24.14M | 23.99M | +0.7% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $732.00K | -$117.69M | -$29.66M | -$74.29M | +100.6% |
| Depreciation & amortisation | $200.74M | $219.51M | $228.77M | $235.15M | -8.6% |
| Stock-based compensation | $55.76M | $46.88M | $40.56M | $36.02M | +18.9% |
| Change in working capital | -$90.04M | -$2.57M | -$135.60M | -$303.73M | -3,405.0% |
| Operating cash flow | $179.85M | $204.03M | $166.20M | -$62.13M | -11.9% |
| Capital expenditure | -$97.02M | -$90.21M | -$93.67M | -$99.33M | -7.5% |
| Investing cash flow | $122.23M | -$88.96M | -$87.95M | -$1.91B | +237.4% |
| Financing cash flow | -$311.52M | -$55.80M | -$35.98M | $1.64B | -458.3% |
| Free cash flow | $82.83M | $113.83M | $72.53M | -$161.46M | -27.2% |
| End cash position | $307.96M | $308.57M | $254.22M | $208.78M | -0.2% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $551.68M | $530.23M | $540.70M | $536.99M | $548.87M | +4.0% |
| Operating revenue | $551.68M | $530.23M | $540.70M | $536.99M | $548.87M | +4.0% |
| Cost of revenue | $316.63M | $324.00M | $337.72M | $336.11M | $340.80M | -2.3% |
| Gross profit | $235.05M | $206.23M | $202.99M | $200.88M | $208.06M | +14.0% |
| Research & development | $22.70M | $21.28M | $21.09M | $21.25M | $21.87M | +6.7% |
| Selling, general & admin | $151.92M | $154.57M | $155.81M | $152.77M | $159.39M | -1.7% |
| Total operating expense | $174.62M | $175.85M | $176.90M | $174.02M | $181.26M | -0.7% |
| Operating income | $60.43M | $30.38M | $26.09M | $26.86M | $26.80M | +98.9% |
| Net interest income | -$15.75M | -$16.49M | -$20.64M | -$19.81M | -$20.55M | +4.5% |
| Pre-tax income | $23.14M | -$3.98M | -$15.90M | -$2.51M | $33.68M | +682.2% |
| Tax provision | $7.07M | -$34.71M | -$2.65M | -$658.00K | $1.18M | +120.4% |
| Net income | $19.09M | $30.13M | -$15.73M | -$3.40M | $35.34M | -36.7% |
| Net income to common | $19.09M | $30.13M | -$15.73M | -$3.40M | $35.34M | -36.7% |
| Basic EPS | 0.76 | 1.22 | -0.64 | -0.14 | 1.43 | -37.7% |
| Diluted EPS | 0.76 | 1.20 | -0.64 | -0.14 | 1.43 | -36.7% |
| EBIT | $41.70M | $14.56M | $6.88M | $19.72M | $56.74M | +186.4% |
| EBITDA | $91.34M | $64.56M | $57.71M | $70.52M | $106.41M | +41.5% |
| Basic shares | 25.00M | 24.76M | 24.69M | 24.69M | 24.64M | +1.0% |
| Diluted shares | 25.04M | 25.18M | 24.69M | 24.69M | 24.71M | -0.5% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $298.30M | $288.33M | $307.96M | $299.73M | $300.02M | — | +3.5% |
| Cash & short-term investments | $298.30M | $288.33M | $307.96M | $299.73M | $300.02M | — | +3.5% |
| Accounts receivable | $183.53M | $201.08M | $180.51M | $191.54M | $179.50M | — | -8.7% |
| Inventory | $607.42M | $605.59M | $615.86M | $622.44M | $616.47M | — | +0.3% |
| Total current assets | $1.21B | $1.21B | $1.19B | $1.21B | $1.18B | — | -0.2% |
| Property, plant & equipment | $485.41M | $495.93M | $511.89M | $512.57M | $511.33M | — | -2.1% |
| Goodwill & intangibles | $2.05B | $2.08B | $2.13B | $2.16B | $2.20B | — | -1.6% |
| Total assets | $3.97B | $4.01B | $4.05B | $4.10B | $4.11B | — | -1.1% |
| Total current liabilities | $498.36M | $517.90M | $498.86M | $492.90M | $482.78M | — | -3.8% |
| Current debt | $18.75M | $18.75M | $18.75M | — | — | $47.81M | 0.0% |
| Long-term debt | $1.21B | $1.26B | $1.27B | $1.31B | $1.34B | — | -3.9% |
| Total debt | $1.27B | $1.33B | $1.33B | $1.36B | $1.39B | — | -4.1% |
| Total liabilities | $1.82B | $1.90B | $1.93B | $1.98B | $1.99B | — | -4.3% |
| Retained earnings | $740.11M | $721.02M | $690.89M | $706.62M | $710.02M | — | +2.6% |
| Shareholder equity | $2.15B | $2.11B | $2.12B | $2.13B | $2.12B | — | +1.9% |
| Working capital | $712.54M | $695.34M | $691.69M | $714.39M | $697.34M | — | +2.5% |
| Net tangible assets | $99.80M | $27.40M | -$9.49M | -$36.34M | -$84.15M | — | +264.3% |
| Shares issued | 25.01M | 25.19M | 24.69M | 24.69M | 24.69M | — | -0.7% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $19.09M | $30.13M | -$15.73M | -$3.40M | $35.34M | -36.7% |
| Depreciation & amortisation | $49.64M | $50.00M | $50.83M | $50.80M | $49.66M | -0.7% |
| Stock-based compensation | $11.87M | $14.01M | $13.88M | $15.24M | $14.46M | -15.3% |
| Change in working capital | -$14.50M | -$63.94M | -$6.84M | -$22.21M | -$49.08M | +77.3% |
| Operating cash flow | $80.15M | $38.91M | $60.60M | $56.71M | $11.21M | +106.0% |
| Capital expenditure | -$20.16M | -$13.21M | -$26.41M | -$31.75M | -$22.00M | -52.6% |
| Investing cash flow | -$20.14M | -$11.21M | -$18.39M | -$30.03M | $187.46M | -79.7% |
| Financing cash flow | -$50.23M | -$44.12M | -$34.48M | -$25.69M | -$195.01M | -13.9% |
| Free cash flow | $59.99M | $25.70M | $34.19M | $24.96M | -$10.79M | +133.4% |
| End cash position | $298.30M | $288.33M | $307.96M | $299.73M | $300.02M | +3.5% |
Options analytics
Put / call volume
0.00
Call-heavy session
Put / call open interest
0.18
Positioning, not flow
Max pain
165.00
+3.3% from spot
ATM implied vol
44.8%
Nearest strike to spot
Skew (10% OTM)
+16.7%
Puts bid over calls
Call volume
490
Contracts, this expiry
Put volume
1
Contracts, this expiry
Heaviest call OI
170.00
110 contracts
Heaviest put OI
165.00
20 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 1.91 | 2.37 | +23.8% |
| Mar 2026 | 1.75 | 1.97 | +12.5% |
| Dec 2025 | 1.69 | 1.91 | +12.8% |
| Sep 2025 | 1.43 | 2.03 | +41.6% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 2.15 | 7 | $553.93M | +3.2% |
| Next quarter | 2.23 | 7 | $561.57M | +4.8% |
| Current year | 8.75 | 8 | $2.19B | -1.0% |
| Next year | 9.65 | 8 | $2.29B | +4.4% |
Analyst targets & ownership
Mean target$193.38
High target$210.00
Low target$178.00
Implied upside21.06%
Analyst count8
ConsensusBUY
Strong buy / Buy3 / 4
Hold1
Sell / Strong sell0 / 0
Held by insiders1.75%
Held by institutions115.80%
Institutions holding397
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
162.00
-1.40% from price
SMA 20
159.28
+0.28% from price
SMA 50
168.98
-5.47% from price
SMA 100
156.34
+2.17% from price
SMA 200
147.16
+8.54% from price
EMA 12
160.75
-0.64% from price
EMA 26
162.56
-1.74% from price
EMA 50
162.74
-1.85% from price
RSI (14)
44.8
Neutral
MACD (12,26,9)
-1.81
Hist 0.41
ATR (14)
4.58
2.87% of price
Realised vol 30D
24.6%
Annualised
Bollinger upper
166.91
20, 2σ
Bollinger lower
151.65
20, 2σ
50 / 200 cross
Golden
168.98 vs 147.16
Trend bias
Above 200
+8.54%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
1.02
More volatile than market
Correlation to SPY
0.38
Loosely linked
Realised vol 30D
24.6%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-27.2%
Peak to trough
Max drawdown 5Y
-67.2%
Peak to trough
ATR 14
4.58
2.87% of price
Beta (reported)
0.87
5Y monthly, from filing
Short interest
Shares short
1.52M
Prior 1.38M
Change vs prior
+9.5%
Shorts adding
% of float
7.26%
Normal
% of shares out
6.06%
Against total outstanding
Days to cover
6.6
Crowded exit
Float
24.56M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 7, 26 | Piper Sandler | MAINTAINED | Overweight | Overweight |
| Aug 7, 26 | BTIG | MAINTAINED | Buy | Buy |
| Aug 7, 26 | Needham | MAINTAINED | Buy | Buy |
| Jul 21, 26 | Keybanc | MAINTAINED | Overweight | Overweight |
| Jun 15, 26 | BTIG | INITIATED | — | Buy |
| May 27, 26 | Needham | UPGRADE | Hold | Buy |
| Apr 27, 26 | Keybanc | MAINTAINED | Overweight | Overweight |
| Apr 17, 26 | Piper Sandler | MAINTAINED | Overweight | Overweight |
| Feb 20, 26 | Keybanc | MAINTAINED | Overweight | Overweight |
| Feb 20, 26 | Piper Sandler | MAINTAINED | Overweight | Overweight |
| Nov 7, 25 | Keybanc | MAINTAINED | Overweight | Overweight |
| Nov 7, 25 | Piper Sandler | MAINTAINED | Overweight | Overweight |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split3:2
Split dateMar 18, 2002
SEC filings
Periodic Financial Reports
10-Q · 2026-08-06
Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)
SD · 2026-06-01
Corporate Changes & Voting Matters
8-K · 2026-05-18
Corporate Changes & Voting Matters
8-K · 2026-05-07
Annual Report to Shareholders
ARS · 2026-04-02
Proxy Statements
PRE 14A · 2026-03-23
Corporate Changes & Voting Matters
8-K · 2026-02-20
Corporate Changes & Voting Matters
8-K · 2026-02-19
Headlines
2 Volatile Stocks to Target This Week and 1 We Turn Down
StockStory · 9d ago
ICU Medical (ICUI) Stock May Be 26% Undervalued On Cash Flow
Simply Wall St. · 18d ago
Vascular Access Device Market by Type, Route of Insertion, Application, End User - Global Forecast to 2031
GlobeNewswire · 19d ago
ICU Medical CFO Sells 6,381 Shares for $1.1 Million
Motley Fool · 19d ago
ICU Medical CFO Brian Bonnell Sells 9,307 Shares
Motley Fool · 20d ago
BAX Raises 2026 Outlook as Strong Q2 Growth Offsets Margin Pressure
Zacks · 29d ago
Drug Reconstitution Systems Market Trends, Shares and Growth Opportunities Worldwide 2026-2035 Featuring Profiles of Baxter, ICU Medical, B. Braun, Vetter Pharma, Nipro, SCHOTT-KAISHA
GlobeNewswire · 30d ago
ICU Medical Insider Sold Shares Worth $1,116,675, According to a Recent SEC Filing
MT Newswires · 35d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.